首页> 外文期刊>The Open Clinical Chemistry Journal >Lipoprotein (a) and Stroke: An Overview~!2009-10-29~!2009-12-27~!2010-04-08~!
【24h】

Lipoprotein (a) and Stroke: An Overview~!2009-10-29~!2009-12-27~!2010-04-08~!

机译:脂蛋白(a)和中风:概述〜!2009-10-29〜!2009-12-27〜!2010-04-08〜!

获取原文
           

摘要

Stroke remains a major cause of mortality and long term severe disability worldwide. Lipoprotein (a) [Lp(a)] is a predictor of many forms of vascular disease, and may serve as a tool in identifying subjects at risk. Despite accumulating evidence from cross sectional and prospective studies, its role in the development of stroke is still in doubt. Methodological issues regarding measurement remain to be resolved. Whether reductions in Lp(a) levels will result in a reduction of vascular events, including stroke, remains to be established. Aggressive management of established cardiovascular risk factors is advocated in subjects exhibiting elevated serum Lp(a) concentrations.
机译:中风仍然是世界范围内导致死亡和长期严重残疾的主要原因。脂蛋白(a)[Lp(a)]是多种形式的血管疾病的预测因子,可作为识别高危受试者的工具。尽管积累了横断面和前瞻性研究的证据,但其在中风发展中的作用仍存在疑问。有关测量的方法学问题仍有待解决。 Lp(a)水平的降低是否会导致血管事件(包括中风)的减少尚待确定。在血清Lp(a)浓度升高的受试者中主张积极管理已建立的心血管危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号